|
1. Biologie
|
|
|
|
Breast cancer’s spread may be influenced by circadian gene [Reuters]
|
|
|
|
|
|
In
mouse studies, researchers showed how having slightly different
versions of gene called Arntl2 can aid the spread of cancer cells. When
they analyzed the genes of breast cancer patients, they also found that
at least one version of Arntl2 was indeed linked to how long the women
survived disease-free.
|
|
|
|
|
|
|
3.1 Tabac
|
|
|
|
5. Traitements
|
|
|
|
5.10 Traitements - Essais
|
|
|
|
5.12 Immunothérapies
|
|
|
|
German next-gen checkpoint inhibitor startup reels in €40M [FierceBiotech]
|
|
|
|
|
|
The
German startup is based on systematic screening of human tumor cells to
find new targets and then analyze their mechanism of action. It is
basing its research efforts on 6 immune-oncology targets. The idea is to
create "organ-specific tumor evasion strategies" as the basis of
next-gen cancer immunotherapy.
|
|
|
|
|
|
|
5.2 Pharma
|
|
|
|
|
5.3 Traitements - FDA, EMA,...
|
|
|
|
|
5.6 ESMO
|
|
|
Precision medicine trial first of its kind to show benefit to patients [ESMO]
|
|
|
|
|
|
Results
from the trial, which took place at the Gustave Roussy Cancer Campus in
Paris, found that 199 out of 1110 patients with advanced cancer, who
had their genes mapped and their treatment tailored, had around 30 per
cent longer before their cancer started growing again compared to any of
the previous therapies the patients had tried. This ranged from between
five and 32 months.
|
|
|
|
|
|
|
6. Lutte contre les cancers
|
|
|
Forging Collaborations to Spur Global Progress against Cancer [NCI]
|
|
|
|
|
|
In
addition to Australia, proteogenomics MOUs were signed with research
institutions in Canada, Germany, China, Korea, Taiwan, and Switzerland.
The United Nations General Assembly meetings also offered an opportunity
to discuss other potential collaborations with health leaders from many
countries.
|
|
|
|
|
|
|
6.11 Patients
|
|
|
|
6.3 Associations/Fondations
|
|
|
|
|
|
6.7.1 Bioinformatique
|
|
|
|
6.9 Controverses
|
|
|